Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Ed Mayer who wrote (674)	11/16/1999 8:45:00 AM
From: Gary Korn	Respond to of 10345

what are your feelings concerning (or trust in) Elan's management? ELN management seems pretty savvy to me: 1. They handled the SEC inquiry well. 2. They are willing to wait on Zonagren for better labeling (more uses). 3. They refused to do a dilutive Medeva acquisition. 4. They've put together an exceptionally informative investor relations web-site. I recall similar "mistrust" in NITE management when the stock sank to 22, and in ASND management when it fell to 22. In but a few weeks, NITE is at 45 and ASND, of course, ultimately was acquired. ELN being a pharma, it may not run up as fast, but ultimately it will turn up. So I'm accumulating. Gary Korn